BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?
BioNTech SE (NASDAQ:BNTX) is ending a mid-stage study of its personalized mRNA cancer vaccine, autogene cevumeran, after an…
Apple Watch Series 11 and SE 3 Preorders: What’s New This Year
Apple 2025-09-11T19:49:44Z Share Facebook Email X LinkedIn Reddit Bluesky WhatsApp Copy link lighning bolt icon An icon in…